Skip to content

Comparison of Comfort Levels between Very High Power Short Duration (vHPSD) and Traditional High-Power Radiofrequency Ablation in Patients with Atrial Fibrillation

Comparison of Comfort Levels between Very High Power Short Duration (vHPSD) and Traditional High-Power Radiofrequency Ablation in Patients with Atrial Fibrillation

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107571
Enrollment
Unknown
Registered
2025-08-14
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal Atrial Fibrillation

Interventions

Traditional Ablation Group:NA
vHPSD Group:NA

Sponsors

Ningbo Medical Centre Lihuili Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18; 2. Symptomatic paroxysmal atrial fibrillation undergoing pulmonary vein isolation (PVI) ablation for the first time; 3. Sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Reversible atrial fibrillation (e.g., electrolyte imbalance, hyperthyroidism); 2. Previous history of cardiac surgery (previous radiofrequency ablation/all other cardiac surgeries); 3. Severe comorbidities (unstable angina, heart failure, life expectancy < 1 year); 4. Contraindications to radiofrequency ablation for atrial fibrillation, such as left atrial/left atrial appendage thrombus, uncontrolled severe bleeding risk (according to the Chinese Guidelines for the Diagnosis and Treatment of Atrial Fibrillation 2023);

Design outcomes

Primary

MeasureTime frame
Dosage of sedative drugs: total dose of Midazolam (µg), total dose of Fentanyl (µg), intraoperative administration rate (total dose / surgical duration);;VAS Score;model displacement volume;;

Secondary

MeasureTime frame
immediate pulmonary vein isolation success rate, single-circle isolation success rate (whether additional ablation points are needed);;operation time (total duration, radiofrequency time, fluoroscopy time);;peripheral injection fluid intake, ablation catheter fluid usage;;other data such as patient baseline characteristics (age, gender, CHA2DS2-VASc score), body weight and BMI, intraoperative vital signs (blood pressure, oxygen saturation);occurrence of intraoperative complications, side effects of anesthetic drugs (e.g., respiratory depression, nausea and vomiting);;

Countries

China

Contacts

Public ContactCen Zemin

Ningbo Medical Centre Lihuili Hospital

czm218@163.com+86 574 55836208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026